| Primary Care Associates Ps | |
|
4122 Factoria Blvd Se Suite 201 Bellevue WA 98006-4200 | |
| (425) 865-8080 | |
| (425) 865-0977 |
| Full Name | Primary Care Associates Ps |
|---|---|
| Speciality | Family Medicine |
| Location | 4122 Factoria Blvd Se, Bellevue, Washington |
| Authorized Official Name and Position | David J Gamrath (MANAGING PARTNER) |
| Authorized Official Contact | 4258658080 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Primary Care Associates Ps 4122 Factoria Blvd Se Suite 201 Bellevue WA 98006-4200 Ph: (425) 865-8080 | Primary Care Associates Ps 4122 Factoria Blvd Se Suite 201 Bellevue WA 98006-4200 Ph: (425) 865-8080 |
| NPI Number | 1083740823 |
|---|---|
| Provider Enumeration Date | 02/26/2007 |
| Last Update Date | 08/22/2020 |
| Medicare PECOS PAC ID | 4880581842 |
|---|---|
| Medicare Enrollment ID | O20040303000780 |
News Archive
Using a modified version of the CRISPR genome-editing system, MIT researchers have developed a new way to screen for genes that protect against specific diseases.
Melbourne researchers have discovered that the death of immune system cells is an important safeguard against the development of diseases such as type 1 diabetes, rheumatoid arthritis and lupus, which occur when the immune system attacks the body's own tissues.
Final results for the Sunbelt Melanoma Trial, published online this month in the Journal of Clinical Oncology, show that thanks to current diagnostic techniques, most stage III melanoma patients do not benefit from treatment with interferon.
In early test tube and mouse studies, investigators at Johns Hopkins Medicine and the Johns Hopkins Kimmel Cancer Center have found that nonmuscle myosin IIC (MYH14), a protein activated in response to mechanical stress, helps promote metastatic behavior in pancreatic cancer cells, and that the compound 4-hydroxyacetophenone (4-HAP), known to stiffen myosin IIC-containing cells, can send it into overdrive, overwhelming the ability of cells to invade nearby tissue.
University of Maryland researchers have shown a strong association between specific genetic variations and an increased risk of stroke in younger women, adding to the growing evidence of possible genetic influences in stroke.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083740823 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (Washington) | Primary |
| Provider Name | Lisa M Steffensen Gamrath |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1528153418 PECOS PAC ID: 7517091796 Enrollment ID: I20100810001196 |
News Archive
Using a modified version of the CRISPR genome-editing system, MIT researchers have developed a new way to screen for genes that protect against specific diseases.
Melbourne researchers have discovered that the death of immune system cells is an important safeguard against the development of diseases such as type 1 diabetes, rheumatoid arthritis and lupus, which occur when the immune system attacks the body's own tissues.
Final results for the Sunbelt Melanoma Trial, published online this month in the Journal of Clinical Oncology, show that thanks to current diagnostic techniques, most stage III melanoma patients do not benefit from treatment with interferon.
In early test tube and mouse studies, investigators at Johns Hopkins Medicine and the Johns Hopkins Kimmel Cancer Center have found that nonmuscle myosin IIC (MYH14), a protein activated in response to mechanical stress, helps promote metastatic behavior in pancreatic cancer cells, and that the compound 4-hydroxyacetophenone (4-HAP), known to stiffen myosin IIC-containing cells, can send it into overdrive, overwhelming the ability of cells to invade nearby tissue.
University of Maryland researchers have shown a strong association between specific genetic variations and an increased risk of stroke in younger women, adding to the growing evidence of possible genetic influences in stroke.
› Verified 1 days ago
| Provider Name | David J Gamrath |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1952412264 PECOS PAC ID: 7214824275 Enrollment ID: I20101011000021 |
News Archive
Using a modified version of the CRISPR genome-editing system, MIT researchers have developed a new way to screen for genes that protect against specific diseases.
Melbourne researchers have discovered that the death of immune system cells is an important safeguard against the development of diseases such as type 1 diabetes, rheumatoid arthritis and lupus, which occur when the immune system attacks the body's own tissues.
Final results for the Sunbelt Melanoma Trial, published online this month in the Journal of Clinical Oncology, show that thanks to current diagnostic techniques, most stage III melanoma patients do not benefit from treatment with interferon.
In early test tube and mouse studies, investigators at Johns Hopkins Medicine and the Johns Hopkins Kimmel Cancer Center have found that nonmuscle myosin IIC (MYH14), a protein activated in response to mechanical stress, helps promote metastatic behavior in pancreatic cancer cells, and that the compound 4-hydroxyacetophenone (4-HAP), known to stiffen myosin IIC-containing cells, can send it into overdrive, overwhelming the ability of cells to invade nearby tissue.
University of Maryland researchers have shown a strong association between specific genetic variations and an increased risk of stroke in younger women, adding to the growing evidence of possible genetic influences in stroke.
› Verified 1 days ago
| Provider Name | Carol Turek |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1134272214 PECOS PAC ID: 4183853252 Enrollment ID: I20140212001841 |
News Archive
Using a modified version of the CRISPR genome-editing system, MIT researchers have developed a new way to screen for genes that protect against specific diseases.
Melbourne researchers have discovered that the death of immune system cells is an important safeguard against the development of diseases such as type 1 diabetes, rheumatoid arthritis and lupus, which occur when the immune system attacks the body's own tissues.
Final results for the Sunbelt Melanoma Trial, published online this month in the Journal of Clinical Oncology, show that thanks to current diagnostic techniques, most stage III melanoma patients do not benefit from treatment with interferon.
In early test tube and mouse studies, investigators at Johns Hopkins Medicine and the Johns Hopkins Kimmel Cancer Center have found that nonmuscle myosin IIC (MYH14), a protein activated in response to mechanical stress, helps promote metastatic behavior in pancreatic cancer cells, and that the compound 4-hydroxyacetophenone (4-HAP), known to stiffen myosin IIC-containing cells, can send it into overdrive, overwhelming the ability of cells to invade nearby tissue.
University of Maryland researchers have shown a strong association between specific genetic variations and an increased risk of stroke in younger women, adding to the growing evidence of possible genetic influences in stroke.
› Verified 1 days ago
News Archive
Using a modified version of the CRISPR genome-editing system, MIT researchers have developed a new way to screen for genes that protect against specific diseases.
Melbourne researchers have discovered that the death of immune system cells is an important safeguard against the development of diseases such as type 1 diabetes, rheumatoid arthritis and lupus, which occur when the immune system attacks the body's own tissues.
Final results for the Sunbelt Melanoma Trial, published online this month in the Journal of Clinical Oncology, show that thanks to current diagnostic techniques, most stage III melanoma patients do not benefit from treatment with interferon.
In early test tube and mouse studies, investigators at Johns Hopkins Medicine and the Johns Hopkins Kimmel Cancer Center have found that nonmuscle myosin IIC (MYH14), a protein activated in response to mechanical stress, helps promote metastatic behavior in pancreatic cancer cells, and that the compound 4-hydroxyacetophenone (4-HAP), known to stiffen myosin IIC-containing cells, can send it into overdrive, overwhelming the ability of cells to invade nearby tissue.
University of Maryland researchers have shown a strong association between specific genetic variations and an increased risk of stroke in younger women, adding to the growing evidence of possible genetic influences in stroke.
› Verified 1 days ago
Mediart Family Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1530 140th Ave Ne Ste 101, Bellevue, WA 98005 Phone: 425-233-8254 Fax: 425-454-7827 | |
Highland Middle School Health Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 15027 Ne Bel Red Rd, Bellevue, WA 98007 Phone: 425-373-3135 | |
Jkw Medical Group Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 11504 Ne 21st St, Bellevue, WA 98004 Phone: 425-698-3033 Fax: 425-968-6357 | |
Hotel California By The Sea Bellevue, Llc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1601 114th Ave Se Ste 180, Bellevue, WA 98004 Phone: 844-766-8717 | |
Healthscan Of Washington Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 6282 119th Ave Se, Bellevue, WA 98006 Phone: 206-922-9951 | |
Rediclinic Of Wa, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3905 Factoria Mall Se, Bellevue, WA 98006 Phone: 713-335-1754 | |
Kaiser Permanente Bellevue Infusion Pharmacy Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3820 Fax: 425-502-3813 |